News News

Xinasou Salt Sol Therapeutic Apparatus Appears at the 2021 Academic Annual Meeting of Respiratory Committee of Hunan Medical Association

Date: 2021-12-20
Views: 21

  From December 17 to 19, 2021, the 2021 Academic Annual Meeting of Respiratory Committee of Hunan Medical Association, sponsored by Hunan Medical Association and organized by Hunan Medical Association Respiratory Committee and Xiangya Hospital of Central South University, was held in Changsha.



  The meeting contents include bronchial asthma, chronic obstructive pulmonary disease (copd), pulmonary infectious disease, pleural disease, interventional lung pathology, lung, pulmonary interstitial diseases, respiratory failure and respiratory intensive care medicine, respiratory diseases, such as pulmonary vascular disease epidemiology, pathogenesis, diagnosis, treatment and related basic research progress.


  Nanjing Kuancheng science and technology Xinashu salt-sol therapeutic instrument as a non-drug treatment for the prevention and treatment of respiratory diseases, appeared in this meeting, for bronchial asthma, chronic obstructive pulmonary disease, pneumoconiosis and other respiratory diseases prevention, treatment, rehabilitation to provide a new means, new program.


  Sinashu salt-sol therapeutic instrument is an effective means to prevent and treat COPD


  Copd is the fourth leading cause of death in China. According to the 2017 World Health Statistics Yearbook, there are 384 million cases of COPD worldwide, and 3.17 million patients die of COPD every year. The prevalence of COPD in China is increasing year by year.


  Salt therapy has been shown to significantly improve immune status, reduce the number of hospitalizations for COPD and improve lung function.


  Sinashu salt-sol therapeutic instrument is being tested in multi-center clinical trials for patients with stable and acute exacerbation of COPD, and has achieved positive feedback:


  A 71-year-old patient with moderate COPD, after 3 months of salt therapy: Perceived improvement in breathing.


  A 71-year-old patient with severe COPD received salt therapy for 3 months and improved expectoration and respiration.


  A 59-year-old patient with severe COPD received salt therapy for 3 months: Sputum excretion was easier and sleep quality was better at night.


  In a 70-year-old patient with moderate COPD, after 3 months of salt therapy, breathing improved and dry vomiting disappeared after brushing teeth in the morning.


  Sinashu salt-sol therapeutic apparatus is an effective means to prevent pneumoconiosis


  Pneumoconiosis is the most serious and common occupational disease in China, as well as the occupational disease with the largest number of cases and the widest range of effects. It not only seriously harms the health and life of patients, but also has become a serious public health problem in China.


  Several studies have shown that salt aerosol therapy can reduce the levels of inflammatory factors IL-6, IL-8 and TNF-α in sputum of patients with pneumoconiosis, and better reduce the airway inflammatory response of patients. It can also reduce the clinical symptoms of patients, instantly improve MVV% and FVC%, so as to improve lung function and quality of life.


  In addition, the National Health Commission in the 'Notice on the pilot work of pneumoconiosis Rehabilitation Station (rehabilitation point) in primary medical institutions' also suggested that conditional pneumoconiosis rehabilitation station can be equipped with salt-sol therapeutic equipment, to prevent patients from developing to severe disease, and can better help patients improve lung function.


  Sinashu salt-sol therapeutic apparatus is an effective means to prevent and treat asthma


  The 2015 Global Burden of Disease study showed that 358 million people in the world suffer from asthma, an increase of 12.6% compared with 1990. The prevalence of adult asthma in Asia ranges from 0.7% to 11.9% (with an average of less than 5%), and the average prevalence of asthma has also been increasing in recent years.


  Li Hongyan, Weng Heng, Wang Lin et al. mentioned in the Mechanism of Clinical Efficacy Set of rock salt aerosol Therapy in the Treatment of patients with bronchial Asthma that combined application of rock salt aerosol therapy and GINA inhalation therapy can rapidly control airway inflammation (IL-4, IFN-γ) in asthmatic patients. The decrease of eosinophil count (IgE) and the improvement of pulmonary function (FEV1) in peripheral blood were more rapid, and the quality of life (ACT score) was significantly improved.


  In the field of childhood asthma, studies have also shown that salt therapy can improve the clinical symptoms of children with asthma, making children cough, wheezing, night wheezing significantly reduced.


  In the prevention, treatment and rehabilitation of respiratory diseases such as asthma, chronic obstructive pulmonary disease, pneumoconiosis, Sinashu salt sol therapeutic instrument can assist drug treatment, help patients to reduce the disease, help the department to reduce the burden of disease.


  In the off-site exhibition area of the conference, many experts stopped to stand at Sinashu, and our sales manager explained the technical details and functional efficacy of the products for customers.




  Sinashu salt sol therapeutic instrument, first of all in the therapy, the use of pure natural, non-drug salt aerosol therapy, composition safety, concentration safety, will not produce side effects on the human body, support human-machine coexistence, and long-term use; Second on the equipment function, can help patients with lower airway inflammation, bactericidal anti-inflammatory, enhance mucus cilia clearance function, promote expectoration drainage, thereby prevent lung infection, relieve the clinical symptoms, improve lung function, reduce the dosage of drugs, increase drug curative effect, reduce the number of hospital, reduce the recurrence rate, improve immunity, improve the quality of life, and so on; Finally, Sinashu salt-sol therapeutic instrument adopts the way of natural breathing, easy to operate, applicable to a wide range of scenarios, suitable for clinical use, at the same time, suitable for patients as a daily use equipment at home.


  Looking forward to the future, Kuan-cheng technology is looking forward to scientific and technological innovation and continuous research and development, and continue to improve the therapeutic instrument of Sinashu salt sol, to solve the clinical problems, to provide prevention and treatment means, to reduce the disease for patients, improve the quality of life, to contribute to the field of respiratory disease prevention and treatment.

Related Content
On the evening of August 18, 2022, Kuancheng Technology held a symposium on gastrointestinal motility. The theme of the conference was 'Application of gastrointestinal motility detection and treat...
2022 - 08 - 19
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disease characterized by abdominal pain, abdominal distension and abdominal discomfort accompanied by changes in defecation habi...
2022 - 07 - 15
'Salt therapy' was recommended by the latest Chinese Expert Consensus on Pneumoconiosis and Lung Rehabilitation!Xinashu rock salt aerosol therapy - a new scheme for lung rehabilitation of pneu...
2022 - 07 - 14
On May 26, 2022, Jiang Wei, deputy director of Jiangsu Drug Administration, visited our company (Nanjing Kuancheng Technology Co., LTD.) to carry out special research on the review and approval of Cla...
2022 - 05 - 27
Functional gastrointestinal diseases, accounting for more than 50% of gastroenterology outpatients. Such as abdominal bloating or flatulence, loss of appetite, early satiety, heartburn, hiccups, belch...
2022 - 05 - 25
(National Service Hotline)
Copyright ©2018 - 2023 Nanjing Kuancheng Technology Co., Ltd
Be lenient towards others and be honest
Share to WeChat friends circle ×
Open WeChat and click "Discovery" at the bottom,
Use "Scan" to share pages with your friends.
Follow us: